-
MANNIN RESEARCH EXECUTIVES ATTENDING OIS@AAO 2016 & AAO
Mannin Research Inc will participate at the the Ophthalmology Innovation Summit and the American Academy of Ophthalmology Annual Meeting in Chicago IL. Mannin Research Inc. will be attending the Ophthalmology Innovation Summit (OIS@AAO 2016), which takes place on October 13th 2016 in Chicago, Illinois. The OIS facilitates meaningful interactions and business partnerships between physicians, entrepreneurs, investors, and industry executives who are driving ophthalmic innovation. The Ophthalmology Innovation Summit is... -
MANNIN RESEARCH INC. CSO DR. SUSAN QUAGGIN ELEQUENTLY DISCUSSES GLAUCOMA AND MAN-01 WITH EYE ON VISION RADIO
Mannin Research Inc. CSO Dr. Susan Quaggin discusses glaucoma, treatment options, and her novel findings on the relationship between Tie2/TEK signaling, Schelmm’s Canal and glaucoma with Eye on Vision. In the interview Dr. Quaggin explains intraocular pressure (IOP), one of the major causes of glaucoma and her research into understanding Tie2/TEK signalling and its relationship with Schlemm’s Canal function and regulation of intra-ocular pressure. Mannin’s researchers have received the... -
MANNIN RESEARCH TO PARTICIPATE AT ARVO 2016 MEETING
Mannin Research Inc. will be attending the Association for Research in Vision and Ophthalmology (ARVO), which takes place from May 1-5, 2016 in Seattle Washington. Mannin Research executives will be meeting with its vendors and research partners. The meeting provides organizations the opportunity to further explore business development goals and other collaborative opportunities for the MAN-01 program for treatment of glaucoma. The ARVO annual meeting is the largest gathering...
